Inhibrx Biosciences
As of the edition of 20 October 2026, Inhibrx Biosciences runs 3 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Stopped | 1 |
| Total | 3 |
Where its trials are
- Cancer: 4 trials led
- Ear, nose and throat: 3 trials led
- Lungs and airways: 3 trials led